Integra Lifesciences Holdings Corp (NASDAQ:IART) is set to release its Q2 2025 earnings on Jul 31, 2025. The consensus ...

Medical device company Integra LifeSciences (NASDAQ:IART) reported Q2 CY2025 results beating Wall Street’s revenue ...

For the current quarter ending in September, Integra expects its per-share earnings to range from 40 cents to 45 cents. The company said it expects revenue in the range of $410 million to $420 million ...

Integra LifeSciences (Nasdaq: IART) shares are on the rise today on second-quarter results that beat the consensus forecast.

The U.S. FDA said on Monday that Integra LifeSciences (NASDAQ:IART) is recalling its MicroMyst Applicators. The recall is due ...

Canada launches its first RTM interoperability trials in Edmonton. AIRmarket and OneSky lead real-world testing for BVLOS ...

Chairperson and overseer of Bora Agro Nigeria Limited, an arm of the Institute of Agricultural Research and Training (IAR&T), ...

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a ...

Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the second ...

Integra LifeSciences faces investor concerns despite attractive valuations, with stagnant growth, rising debt, and questionable earnings quality. Learn more on IART stock here.

The IART Facility will provide critically needed skill and resiliency training for both new and incumbent workers in the Energy, Utility, Digital/AI and other Critical Infrastructure. PITTSBURGH ...